×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions by Myers Scott Dunseth

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
VRDNViridian Therapeutics, Inc.DEMyers Scott DunsethChief Executive OfficerApr 12, 2023Buy$25.374,000101,479259,500Apr 12, 2023, 07:05 PM
VRDNViridian Therapeutics, Inc.DEMyers Scott DunsethChief Executive OfficerMar 13, 2023Buy$29.155,500160,324255,500Mar 13, 2023, 04:06 PM
SELBSELECTA BIOSCIENCES INCMyers Scott DunsethDirectorDec 23, 2019Option Exercise$1.4639,40957,53780,845Dec 26, 2019, 05:29 PM
SELBSELECTA BIOSCIENCES INCMyers Scott DunsethDirectorAug 20, 2019Option Exercise$1.8141,43674,99941,436Aug 20, 2019, 04:32 PM
CASCCascadian Therapeutics, Inc.Myers Scott DunsethPresident and CEOJan 11, 2018Option Exercise$3.923,42913,44256,787Jan 16, 2018, 05:26 PM
CASCCascadian Therapeutics, Inc.Myers Scott DunsethPresident and CEOAug 11, 2017Buy$3.735,50020,54249,716Aug 14, 2017, 05:12 PM
CASCCascadian Therapeutics, Inc.Myers Scott DunsethPresident and CEOMay 12, 2017Buy$4.002,80011,19244,216May 16, 2017, 05:43 PM
CASCCascadian Therapeutics, Inc.Myers Scott DunsethPresident and CEOMar 31, 2017Buy$4.112,0008,22941,416Apr 04, 2017, 05:39 PM
CASCCascadian Therapeutics, Inc.Myers Scott DunsethPresident and CEOMar 20, 2017Buy$3.931,0003,92739,416Mar 21, 2017, 08:09 PM
CASCCascadian Therapeutics, Inc.Myers Scott DunsethPresident and CEOJan 27, 2017Buy$3.7620,50077,03938,416Jan 31, 2017, 04:55 PM
CASCCascadian Therapeutics, Inc.Myers Scott DunsethPresident and CEOAug 17, 2016Buy$1.1545,00051,745107,500Aug 18, 2016, 05:16 PM
CASCCascadian Therapeutics, Inc.Myers Scott DunsethPresident and CEOJun 28, 2016Buy$0.8062,50050,00062,500Jun 28, 2016, 05:36 PM